Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Shingrix in CLL/WM on BTK Inhibitors
NCT03771157Phase 1Completed
- Sponsor
- University of Rochester
- Start
- Feb 2019
- Primary completion
- Sep 2020
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of Zoster vaccine recombinant in herpes zoster (HZ), sponsored by University of Rochester. Primary endpoint: Number of Participants With Humoral Response to Vaccination. Started Feb 2019; status: completed.
02
Drugs
Zoster vaccine recombinant
03
Conditions
herpes zoster (HZ)
Beyond the preview
Go deeper on NCT03771157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03771157.